Bli medlem
Bli medlem

Du är här

2016-04-06

Novavax to Present at the 15th Annual Needham Healthcare Conference

ham Healthcare Conference

GAITHERSBURG, Md., 2016-04-06 22:05 CEST (GLOBE NEWSWIRE) --
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the
discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, today announced Stanley C. Erck, President and Chief
Executive Officer, will present at the 15th Annual Needham Healthcare
Conference.

Conference details are as follows:

Date: Wednesday, April 13, 2016
Time: 8:40 a.m. U.S. Eastern Time
Location: Westin Grand Central hotel, New York City
Live webcast: http://wsw.com/webcast/needham76/nvax

The webcast and a replay of the presentation will also be accessible under the
“Investors/Events” section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation
for ground-breaking innovation that improves global health through safe and
effective vaccines. Additional information about Novavax is available on the
company's website, novavax.com.

Contact: Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations

ir@novavax.com
240-268-2000

Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.

david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.